Pharma & Healthcare
Global Tildrakizumab Market Research Report 2024
- Jan 18, 24
- ID: 3188
- Pages: 69
- Figures: 157
- Views: 28
Tildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoriasis.
The global Tildrakizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tildrakizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tildrakizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tildrakizumab include Sun Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tildrakizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tildrakizumab.
Report Scope
The Tildrakizumab market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tildrakizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tildrakizumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sun Pharma
Segment by Type
18MIU /Vial
25MIU /Vial
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tildrakizumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tildrakizumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Tildrakizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tildrakizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tildrakizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tildrakizumab include Sun Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tildrakizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tildrakizumab.
Report Scope
The Tildrakizumab market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tildrakizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tildrakizumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sun Pharma
Segment by Type
18MIU /Vial
25MIU /Vial
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tildrakizumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tildrakizumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Tildrakizumab Market Overview
1.1 Product Overview and Scope of Tildrakizumab
1.2 Tildrakizumab Segment by Type
1.2.1 Global Tildrakizumab Market Value Comparison by Type (2024-2030)
1.2.2 18MIU /Vial
1.2.3 25MIU /Vial
1.3 Tildrakizumab Segment by Application
1.3.1 Global Tildrakizumab Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Tildrakizumab Market Size Estimates and Forecasts
1.4.1 Global Tildrakizumab Revenue 2019-2030
1.4.2 Global Tildrakizumab Sales 2019-2030
1.4.3 Global Tildrakizumab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tildrakizumab Market Competition by Manufacturers
2.1 Global Tildrakizumab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tildrakizumab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tildrakizumab Average Price by Manufacturers (2019-2024)
2.4 Global Tildrakizumab Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tildrakizumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tildrakizumab, Product Type & Application
2.7 Tildrakizumab Market Competitive Situation and Trends
2.7.1 Tildrakizumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tildrakizumab Players Market Share by Revenue
2.7.3 Global Tildrakizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tildrakizumab Retrospective Market Scenario by Region
3.1 Global Tildrakizumab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tildrakizumab Global Tildrakizumab Sales by Region: 2019-2030
3.2.1 Global Tildrakizumab Sales by Region: 2019-2024
3.2.2 Global Tildrakizumab Sales by Region: 2025-2030
3.3 Global Tildrakizumab Global Tildrakizumab Revenue by Region: 2019-2030
3.3.1 Global Tildrakizumab Revenue by Region: 2019-2024
3.3.2 Global Tildrakizumab Revenue by Region: 2025-2030
3.4 North America Tildrakizumab Market Facts & Figures by Country
3.4.1 North America Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tildrakizumab Sales by Country (2019-2030)
3.4.3 North America Tildrakizumab Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tildrakizumab Market Facts & Figures by Country
3.5.1 Europe Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tildrakizumab Sales by Country (2019-2030)
3.5.3 Europe Tildrakizumab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tildrakizumab Market Facts & Figures by Country
3.6.1 Asia Pacific Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tildrakizumab Sales by Country (2019-2030)
3.6.3 Asia Pacific Tildrakizumab Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tildrakizumab Market Facts & Figures by Country
3.7.1 Latin America Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tildrakizumab Sales by Country (2019-2030)
3.7.3 Latin America Tildrakizumab Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tildrakizumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tildrakizumab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tildrakizumab Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tildrakizumab Sales by Type (2019-2030)
4.1.1 Global Tildrakizumab Sales by Type (2019-2024)
4.1.2 Global Tildrakizumab Sales by Type (2025-2030)
4.1.3 Global Tildrakizumab Sales Market Share by Type (2019-2030)
4.2 Global Tildrakizumab Revenue by Type (2019-2030)
4.2.1 Global Tildrakizumab Revenue by Type (2019-2024)
4.2.2 Global Tildrakizumab Revenue by Type (2025-2030)
4.2.3 Global Tildrakizumab Revenue Market Share by Type (2019-2030)
4.3 Global Tildrakizumab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tildrakizumab Sales by Application (2019-2030)
5.1.1 Global Tildrakizumab Sales by Application (2019-2024)
5.1.2 Global Tildrakizumab Sales by Application (2025-2030)
5.1.3 Global Tildrakizumab Sales Market Share by Application (2019-2030)
5.2 Global Tildrakizumab Revenue by Application (2019-2030)
5.2.1 Global Tildrakizumab Revenue by Application (2019-2024)
5.2.2 Global Tildrakizumab Revenue by Application (2025-2030)
5.2.3 Global Tildrakizumab Revenue Market Share by Application (2019-2030)
5.3 Global Tildrakizumab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sun Pharma
6.1.1 Sun Pharma Corporation Information
6.1.2 Sun Pharma Description and Business Overview
6.1.3 Sun Pharma Tildrakizumab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sun Pharma Tildrakizumab Product Portfolio
6.1.5 Sun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tildrakizumab Industry Chain Analysis
7.2 Tildrakizumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tildrakizumab Production Mode & Process
7.4 Tildrakizumab Sales and Marketing
7.4.1 Tildrakizumab Sales Channels
7.4.2 Tildrakizumab Distributors
7.5 Tildrakizumab Customers
8 Tildrakizumab Market Dynamics
8.1 Tildrakizumab Industry Trends
8.2 Tildrakizumab Market Drivers
8.3 Tildrakizumab Market Challenges
8.4 Tildrakizumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Tildrakizumab
1.2 Tildrakizumab Segment by Type
1.2.1 Global Tildrakizumab Market Value Comparison by Type (2024-2030)
1.2.2 18MIU /Vial
1.2.3 25MIU /Vial
1.3 Tildrakizumab Segment by Application
1.3.1 Global Tildrakizumab Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Tildrakizumab Market Size Estimates and Forecasts
1.4.1 Global Tildrakizumab Revenue 2019-2030
1.4.2 Global Tildrakizumab Sales 2019-2030
1.4.3 Global Tildrakizumab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tildrakizumab Market Competition by Manufacturers
2.1 Global Tildrakizumab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tildrakizumab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tildrakizumab Average Price by Manufacturers (2019-2024)
2.4 Global Tildrakizumab Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tildrakizumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tildrakizumab, Product Type & Application
2.7 Tildrakizumab Market Competitive Situation and Trends
2.7.1 Tildrakizumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tildrakizumab Players Market Share by Revenue
2.7.3 Global Tildrakizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tildrakizumab Retrospective Market Scenario by Region
3.1 Global Tildrakizumab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tildrakizumab Global Tildrakizumab Sales by Region: 2019-2030
3.2.1 Global Tildrakizumab Sales by Region: 2019-2024
3.2.2 Global Tildrakizumab Sales by Region: 2025-2030
3.3 Global Tildrakizumab Global Tildrakizumab Revenue by Region: 2019-2030
3.3.1 Global Tildrakizumab Revenue by Region: 2019-2024
3.3.2 Global Tildrakizumab Revenue by Region: 2025-2030
3.4 North America Tildrakizumab Market Facts & Figures by Country
3.4.1 North America Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tildrakizumab Sales by Country (2019-2030)
3.4.3 North America Tildrakizumab Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tildrakizumab Market Facts & Figures by Country
3.5.1 Europe Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tildrakizumab Sales by Country (2019-2030)
3.5.3 Europe Tildrakizumab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tildrakizumab Market Facts & Figures by Country
3.6.1 Asia Pacific Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tildrakizumab Sales by Country (2019-2030)
3.6.3 Asia Pacific Tildrakizumab Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tildrakizumab Market Facts & Figures by Country
3.7.1 Latin America Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tildrakizumab Sales by Country (2019-2030)
3.7.3 Latin America Tildrakizumab Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tildrakizumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Tildrakizumab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tildrakizumab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tildrakizumab Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tildrakizumab Sales by Type (2019-2030)
4.1.1 Global Tildrakizumab Sales by Type (2019-2024)
4.1.2 Global Tildrakizumab Sales by Type (2025-2030)
4.1.3 Global Tildrakizumab Sales Market Share by Type (2019-2030)
4.2 Global Tildrakizumab Revenue by Type (2019-2030)
4.2.1 Global Tildrakizumab Revenue by Type (2019-2024)
4.2.2 Global Tildrakizumab Revenue by Type (2025-2030)
4.2.3 Global Tildrakizumab Revenue Market Share by Type (2019-2030)
4.3 Global Tildrakizumab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tildrakizumab Sales by Application (2019-2030)
5.1.1 Global Tildrakizumab Sales by Application (2019-2024)
5.1.2 Global Tildrakizumab Sales by Application (2025-2030)
5.1.3 Global Tildrakizumab Sales Market Share by Application (2019-2030)
5.2 Global Tildrakizumab Revenue by Application (2019-2030)
5.2.1 Global Tildrakizumab Revenue by Application (2019-2024)
5.2.2 Global Tildrakizumab Revenue by Application (2025-2030)
5.2.3 Global Tildrakizumab Revenue Market Share by Application (2019-2030)
5.3 Global Tildrakizumab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sun Pharma
6.1.1 Sun Pharma Corporation Information
6.1.2 Sun Pharma Description and Business Overview
6.1.3 Sun Pharma Tildrakizumab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sun Pharma Tildrakizumab Product Portfolio
6.1.5 Sun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tildrakizumab Industry Chain Analysis
7.2 Tildrakizumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tildrakizumab Production Mode & Process
7.4 Tildrakizumab Sales and Marketing
7.4.1 Tildrakizumab Sales Channels
7.4.2 Tildrakizumab Distributors
7.5 Tildrakizumab Customers
8 Tildrakizumab Market Dynamics
8.1 Tildrakizumab Industry Trends
8.2 Tildrakizumab Market Drivers
8.3 Tildrakizumab Market Challenges
8.4 Tildrakizumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tildrakizumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tildrakizumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tildrakizumab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tildrakizumab Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tildrakizumab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tildrakizumab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tildrakizumab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tildrakizumab Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tildrakizumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tildrakizumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tildrakizumab, Product Type & Application
Table 12. Global Key Manufacturers of Tildrakizumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tildrakizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tildrakizumab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tildrakizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tildrakizumab Sales by Region (2019-2024) & (K Units)
Table 18. Global Tildrakizumab Sales Market Share by Region (2019-2024)
Table 19. Global Tildrakizumab Sales by Region (2025-2030) & (K Units)
Table 20. Global Tildrakizumab Sales Market Share by Region (2025-2030)
Table 21. Global Tildrakizumab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tildrakizumab Revenue Market Share by Region (2019-2024)
Table 23. Global Tildrakizumab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tildrakizumab Revenue Market Share by Region (2025-2030)
Table 25. North America Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 27. North America Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 28. North America Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tildrakizumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tildrakizumab Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tildrakizumab Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tildrakizumab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tildrakizumab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tildrakizumab Sales (K Units) by Type (2019-2024)
Table 51. Global Tildrakizumab Sales (K Units) by Type (2025-2030)
Table 52. Global Tildrakizumab Sales Market Share by Type (2019-2024)
Table 53. Global Tildrakizumab Sales Market Share by Type (2025-2030)
Table 54. Global Tildrakizumab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tildrakizumab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tildrakizumab Revenue Market Share by Type (2019-2024)
Table 57. Global Tildrakizumab Revenue Market Share by Type (2025-2030)
Table 58. Global Tildrakizumab Price (USD/Unit) by Type (2019-2024)
Table 59. Global Tildrakizumab Price (USD/Unit) by Type (2025-2030)
Table 60. Global Tildrakizumab Sales (K Units) by Application (2019-2024)
Table 61. Global Tildrakizumab Sales (K Units) by Application (2025-2030)
Table 62. Global Tildrakizumab Sales Market Share by Application (2019-2024)
Table 63. Global Tildrakizumab Sales Market Share by Application (2025-2030)
Table 64. Global Tildrakizumab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tildrakizumab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tildrakizumab Revenue Market Share by Application (2019-2024)
Table 67. Global Tildrakizumab Revenue Market Share by Application (2025-2030)
Table 68. Global Tildrakizumab Price (USD/Unit) by Application (2019-2024)
Table 69. Global Tildrakizumab Price (USD/Unit) by Application (2025-2030)
Table 70. Sun Pharma Corporation Information
Table 71. Sun Pharma Description and Business Overview
Table 72. Sun Pharma Tildrakizumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Sun Pharma Tildrakizumab Product
Table 74. Sun Pharma Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Tildrakizumab Distributors List
Table 78. Tildrakizumab Customers List
Table 79. Tildrakizumab Market Trends
Table 80. Tildrakizumab Market Drivers
Table 81. Tildrakizumab Market Challenges
Table 82. Tildrakizumab Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tildrakizumab
Figure 2. Global Tildrakizumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tildrakizumab Market Share by Type in 2023 & 2030
Figure 4. 18MIU /Vial Product Picture
Figure 5. 25MIU /Vial Product Picture
Figure 6. Global Tildrakizumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tildrakizumab Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Tildrakizumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Tildrakizumab Market Size (2019-2030) & (US$ Million)
Figure 12. Global Tildrakizumab Sales (2019-2030) & (K Units)
Figure 13. Global Tildrakizumab Average Price (USD/Unit) & (2019-2030)
Figure 14. Tildrakizumab Report Years Considered
Figure 15. Tildrakizumab Sales Share by Manufacturers in 2023
Figure 16. Global Tildrakizumab Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Tildrakizumab Players: Market Share by Revenue in 2023
Figure 18. Tildrakizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Tildrakizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 21. North America Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 25. Europe Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 26. Germany Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Tildrakizumab Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Tildrakizumab Revenue Market Share by Region (2019-2030)
Figure 33. China Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 44. Latin America Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Tildrakizumab by Type (2019-2030)
Figure 54. Global Revenue Market Share of Tildrakizumab by Type (2019-2030)
Figure 55. Global Tildrakizumab Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Tildrakizumab by Application (2019-2030)
Figure 57. Global Revenue Market Share of Tildrakizumab by Application (2019-2030)
Figure 58. Global Tildrakizumab Price (USD/Unit) by Application (2019-2030)
Figure 59. Tildrakizumab Value Chain
Figure 60. Tildrakizumab Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Tildrakizumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tildrakizumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tildrakizumab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tildrakizumab Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tildrakizumab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tildrakizumab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tildrakizumab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tildrakizumab Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tildrakizumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tildrakizumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tildrakizumab, Product Type & Application
Table 12. Global Key Manufacturers of Tildrakizumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tildrakizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tildrakizumab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tildrakizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tildrakizumab Sales by Region (2019-2024) & (K Units)
Table 18. Global Tildrakizumab Sales Market Share by Region (2019-2024)
Table 19. Global Tildrakizumab Sales by Region (2025-2030) & (K Units)
Table 20. Global Tildrakizumab Sales Market Share by Region (2025-2030)
Table 21. Global Tildrakizumab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tildrakizumab Revenue Market Share by Region (2019-2024)
Table 23. Global Tildrakizumab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tildrakizumab Revenue Market Share by Region (2025-2030)
Table 25. North America Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 27. North America Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 28. North America Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tildrakizumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tildrakizumab Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tildrakizumab Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tildrakizumab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tildrakizumab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tildrakizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tildrakizumab Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tildrakizumab Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tildrakizumab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tildrakizumab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tildrakizumab Sales (K Units) by Type (2019-2024)
Table 51. Global Tildrakizumab Sales (K Units) by Type (2025-2030)
Table 52. Global Tildrakizumab Sales Market Share by Type (2019-2024)
Table 53. Global Tildrakizumab Sales Market Share by Type (2025-2030)
Table 54. Global Tildrakizumab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tildrakizumab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tildrakizumab Revenue Market Share by Type (2019-2024)
Table 57. Global Tildrakizumab Revenue Market Share by Type (2025-2030)
Table 58. Global Tildrakizumab Price (USD/Unit) by Type (2019-2024)
Table 59. Global Tildrakizumab Price (USD/Unit) by Type (2025-2030)
Table 60. Global Tildrakizumab Sales (K Units) by Application (2019-2024)
Table 61. Global Tildrakizumab Sales (K Units) by Application (2025-2030)
Table 62. Global Tildrakizumab Sales Market Share by Application (2019-2024)
Table 63. Global Tildrakizumab Sales Market Share by Application (2025-2030)
Table 64. Global Tildrakizumab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tildrakizumab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tildrakizumab Revenue Market Share by Application (2019-2024)
Table 67. Global Tildrakizumab Revenue Market Share by Application (2025-2030)
Table 68. Global Tildrakizumab Price (USD/Unit) by Application (2019-2024)
Table 69. Global Tildrakizumab Price (USD/Unit) by Application (2025-2030)
Table 70. Sun Pharma Corporation Information
Table 71. Sun Pharma Description and Business Overview
Table 72. Sun Pharma Tildrakizumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Sun Pharma Tildrakizumab Product
Table 74. Sun Pharma Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Tildrakizumab Distributors List
Table 78. Tildrakizumab Customers List
Table 79. Tildrakizumab Market Trends
Table 80. Tildrakizumab Market Drivers
Table 81. Tildrakizumab Market Challenges
Table 82. Tildrakizumab Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tildrakizumab
Figure 2. Global Tildrakizumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tildrakizumab Market Share by Type in 2023 & 2030
Figure 4. 18MIU /Vial Product Picture
Figure 5. 25MIU /Vial Product Picture
Figure 6. Global Tildrakizumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tildrakizumab Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Tildrakizumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Tildrakizumab Market Size (2019-2030) & (US$ Million)
Figure 12. Global Tildrakizumab Sales (2019-2030) & (K Units)
Figure 13. Global Tildrakizumab Average Price (USD/Unit) & (2019-2030)
Figure 14. Tildrakizumab Report Years Considered
Figure 15. Tildrakizumab Sales Share by Manufacturers in 2023
Figure 16. Global Tildrakizumab Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Tildrakizumab Players: Market Share by Revenue in 2023
Figure 18. Tildrakizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Tildrakizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 21. North America Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 25. Europe Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 26. Germany Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Tildrakizumab Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Tildrakizumab Revenue Market Share by Region (2019-2030)
Figure 33. China Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 44. Latin America Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Tildrakizumab Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Tildrakizumab Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Tildrakizumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Tildrakizumab by Type (2019-2030)
Figure 54. Global Revenue Market Share of Tildrakizumab by Type (2019-2030)
Figure 55. Global Tildrakizumab Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Tildrakizumab by Application (2019-2030)
Figure 57. Global Revenue Market Share of Tildrakizumab by Application (2019-2030)
Figure 58. Global Tildrakizumab Price (USD/Unit) by Application (2019-2030)
Figure 59. Tildrakizumab Value Chain
Figure 60. Tildrakizumab Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232